Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria
- 1 July 2003
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (1) , 212-213
- https://doi.org/10.1067/mai.2003.1559
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialEuropean Respiratory Journal, 1999
- Inhibitory Effect of Loratadine on Leukotriene B4Production by Neutrophils Either Alone or During Interaction with Human Airway Epithelial CellsPulmonary Pharmacology & Therapeutics, 1998
- Sequential Therapy with Nimesulide and Ketotifen in Delayed Pressure UrticariaActa Dermato-Venereologica, 1998
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Urinary leukotriene E4levels in patients with atopic dermatitisBritish Journal of Dermatology, 1997
- Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjectsJournal of Allergy and Clinical Immunology, 1990
- Leukotriene E4 release in cold urticariaClinical and Experimental Allergy, 1989
- Leukotrienes and Airway ResponsesAmerican Review of Respiratory Disease, 1987
- Clinical, pharmacological and immunological aspects of delayed pressure urticariaBritish Journal of Dermatology, 1984